Posted by Michael Wonder on 01 Aug 2025
Lenz Therapeutics announces US FDA approval of Vizz for the treatment of presbyopia
31 July 2025 - Vizz samples and product availability in the US expected as early as October 2025.
Lenz Therapeutics today announced the US FDA approved Vizz (aceclidine ophthalmic solution) 1.44%, the first and only FDA approved aceclidine-based eye drop for the treatment of presbyopia in adults.
